MA38279A1 - Therapeutically active pyrazolo-pyrimidine derivatives - Google Patents
Therapeutically active pyrazolo-pyrimidine derivativesInfo
- Publication number
- MA38279A1 MA38279A1 MA38279A MA38279A MA38279A1 MA 38279 A1 MA38279 A1 MA 38279A1 MA 38279 A MA38279 A MA 38279A MA 38279 A MA38279 A MA 38279A MA 38279 A1 MA38279 A1 MA 38279A1
- Authority
- MA
- Morocco
- Prior art keywords
- pyrimidine derivatives
- therapeutically active
- pyrazolo
- active pyrazolo
- spirocyclic
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Cette invention concerne une série de dérivés de pyrazolo[3,4-d]pyrimidine qui sont substitués à la position 4 par un fragment monocyclique, bicyclique ponté ou spirocyclique de type diaza, qui sont bénéfiques pour traiter et/ou prévenir diverses maladies humaines, comprenant les troubles inflammatoires, autoimmuns et oncologiques ; les maladies virales et le paludisme ; et le rejet de greffes d'organes et de cellules.This invention relates to a series of pyrazolo [3,4-d] pyrimidine derivatives which are substituted at the 4-position by a monocyclic, bridged bicyclic or spirocyclic diaza moiety, which are beneficial for treating and / or preventing various human diseases, including inflammatory, autoimmune and oncological disorders; viral diseases and malaria; and rejection of organ and cell transplants.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1223021.5A GB201223021D0 (en) | 2012-12-20 | 2012-12-20 | Therapeutic agents |
PCT/EP2013/077846 WO2014096423A1 (en) | 2012-12-20 | 2013-12-20 | Therapeutically active pyrazolo-pyrimidine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
MA38279A1 true MA38279A1 (en) | 2018-02-28 |
MA38279B1 MA38279B1 (en) | 2018-10-31 |
Family
ID=47682284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA38279A MA38279B1 (en) | 2012-12-20 | 2013-12-20 | Therapeutically active pyrazolo-pyrimidine derivatives |
Country Status (4)
Country | Link |
---|---|
EC (1) | ECSP15031293A (en) |
GB (1) | GB201223021D0 (en) |
GT (1) | GT201500169A (en) |
MA (1) | MA38279B1 (en) |
-
2012
- 2012-12-20 GB GBGB1223021.5A patent/GB201223021D0/en not_active Ceased
-
2013
- 2013-12-20 MA MA38279A patent/MA38279B1/en unknown
-
2015
- 2015-06-19 GT GT201500169A patent/GT201500169A/en unknown
- 2015-07-20 EC ECIEPI201531293A patent/ECSP15031293A/en unknown
Also Published As
Publication number | Publication date |
---|---|
GT201500169A (en) | 2019-08-30 |
GB201223021D0 (en) | 2013-02-06 |
MA38279B1 (en) | 2018-10-31 |
ECSP15031293A (en) | 2018-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201890827A1 (en) | CONDENSED DERIVATIVES OF PYRAZOL AS KINASE INHIBITORS | |
EA201500654A1 (en) | THERAPEUTICALLY ACTIVE DERIVATIVES OF PYRAZOLOPYRIMIDINE | |
CY1121512T1 (en) | METHODS AND INTERMEDIATIONS FOR THE PREPARATION OF JAK SUSPENDER | |
MA40770B1 (en) | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES | |
EA201100524A1 (en) | AZAINDAZOLES AS ANTAGONISTS OF CCR1 RECEPTOR | |
EA201790228A1 (en) | COMPOSITIONS AND METHODS OF OBTAINING PYRIMIDINE AND PYRIDINE COMPOUNDS WITH BTK INHIBITING ACTIVITY | |
BR112015009942A2 (en) | tricyclic fused thiophene derivatives as jak inhibitors | |
EA201492176A1 (en) | SELECTIVE PI3K DELTA INHIBITORS | |
EA201270480A1 (en) | NEW CONNECTIONS | |
MA52856B1 (en) | Heteroaryl or fused aryl bicyclic compounds and their use as irak4 inhibitors | |
BR112016011484A2 (en) | IMIDAZOPYRIMIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | |
MX2011012353A (en) | N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2, 3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS. | |
EA201492082A1 (en) | CRYSTAL FORMS OF BLUTON TYROSINKINASE INHIBITOR | |
NO20075560L (en) | Purine and imidazopyridine derivatives for immunosuppression | |
EA201690502A1 (en) | SUBSTITUTED PYRIMIDINE INHIBITORS BMI-1 | |
UA111854C2 (en) | METHODS AND INTERMEDIATE COMPOUNDS FOR JAK INHIBITORS | |
EA201990523A1 (en) | NEW SELECTIVE JAK1 INHIBITORS AND THEIR APPLICATION | |
MA37946A1 (en) | Treatment of rheumatoid arthritis | |
CY1119063T1 (en) | SUBSTITUTED BICYCLE DYYDROPYRIMIDINONS AND THEIR USE AS SUSPENSIONS OF BACKGROUND ADJUSTMENT | |
CA2903737C (en) | Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor | |
EA201891897A1 (en) | 1,5-DIGIDRO-4H-PYRAZOLO [3,4-d] PYRIMIDIN-4-ONE and 1,5-DIHYDRO-4H-PYRAZOLO [4,3-c] PYRIDIN-4-ONE AS PDE1 INHIBITORS | |
IN2015DN03751A (en) | ||
TR201901338T4 (en) | Pyrazolo-Pyridine Derivatives as Kinase Inhibitors | |
EA201891710A1 (en) | THERAPEUTIC CONNECTIONS | |
EA201792687A1 (en) | Condensed tricyclic imidazopyrazines as modulators of TNF activity |